{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:27:15Z","timestamp":1782818835333,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68909-3","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T08:02:01Z","timestamp":1723881721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The magnitude of neurocognitive disorders and associated factors among people living with HIV AIDS facilities in Bahir Dar City Ethiopia"],"prefix":"10.1038","volume":"14","author":[{"given":"Meseret","family":"Manaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergoye","family":"Melese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-0191","authenticated-orcid":false,"given":"Gizachew Tadesse","family":"Wassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"68909_CR1","unstructured":"National library of medicine, Neurocognitive disorder. Medline plus found at https:\/\/medlineplus.gov 2022."},{"issue":"1","key":"68909_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4314\/ejhs.v27i1.9","volume":"27","author":"T Belete","year":"2017","unstructured":"Belete, T., Medfu, G. & Yemiyamrew, E. Prevalence of HIV associated neurocognitive deficit among HIV positive people in Ethiopia: A cross sectional study at Ayder Referral Hospital. Ethiop. J. Health Sci. 27(1), 67\u201376 (2017).","journal-title":"Ethiop. J. Health Sci."},{"issue":"6","key":"68909_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.22053","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur, J. C. et al. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann. Neurol. 67(6), 699\u2013714 (2010).","journal-title":"Ann. Neurol."},{"key":"68909_CR4","unstructured":"Weill institute for neuro sciences, A healthcare providers guide to HIV associated neurocognitive disorder (HAND). UCSF HIV dementia providers, 2017."},{"issue":"1","key":"68909_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s15010-019-01373-8","volume":"48","author":"N Ciccarelli","year":"2020","unstructured":"Ciccarelli, N. Considerations on nosology for HIV-associated neurocognitive disorders: It is time to update?. Infection 48(1), 37\u201342 (2020).","journal-title":"Infection"},{"issue":"1","key":"68909_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/QCO.0000000000000328","volume":"30","author":"DB Clifford","year":"2017","unstructured":"Clifford, D. B. HIV-associated neurocognitive disorder. Curr. Opin. Infect. Dis. 30(1), 117\u2013122 (2017).","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"4","key":"68909_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor, D. et al. HIV-associated neurocognitive disorder\u2014Pathogenesis and prospects for treatment. Nat. Rev. Neurol. 12(4), 234\u2013248 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"68909_CR8","doi-asserted-by":"crossref","unstructured":"Ances, B.M. and R.J. Ellis. Dementia and neurocognitive disorders due to HIV-1 infection. in Seminars in neurology. 2007. Copyright\u00a9 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New","DOI":"10.1055\/s-2006-956759"},{"issue":"1","key":"68909_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12981-021-00424-1","volume":"18","author":"Y Zenebe","year":"2021","unstructured":"Zenebe, Y. et al. A systematic review and meta-analysis of HIV associated neurocognitive disorders (HAND) among people with HIV in Ethiopia. AIDS Res. Ther. 18(1), 99 (2021).","journal-title":"AIDS Res. Ther."},{"key":"68909_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.npbr.2020.11.002","volume":"38","author":"GY Yitbarek","year":"2020","unstructured":"Yitbarek, G. Y. et al. Cognitive impairment and its associated factors among HIV\/AIDS patients on anti retro -viral therapy in Sub-Saharan Africa: Systematic review and meta-analysis. Neurol. Psychiatry Brain Res. 38, 83\u201391 (2020).","journal-title":"Neurol. Psychiatry Brain Res."},{"key":"68909_CR11","unstructured":"Araya, T., et al. Prevalence and factors associated with neuro cognitive disorders among HIV-positive patients in Ethiopia: A hospital-based cross-sectional study. Ethiop. J. Health Develop. 34(1) (2020)."},{"issue":"2","key":"68909_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","volume":"146","author":"N Lohse","year":"2007","unstructured":"Lohse, N. et al. Survival of persons with and without HIV infection in Denmark, 1995\u20132005. Ann. Intern. Med. 146(2), 87\u201395 (2007).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"68909_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12905-022-02059-4","volume":"22","author":"WZ Worku","year":"2022","unstructured":"Worku, W. Z. et al. HIV is still a major public health problem among pregnant women attending ANC in Referral Hospitals of the Amhara Regional State, Ethiopia: A cross sectional study. BMC Women\u2019s Health 22(1), 468 (2022).","journal-title":"BMC Women's Health"},{"key":"68909_CR14","first-page":"307","volume":"12","author":"ED Worku","year":"2020","unstructured":"Worku, E. D., Asemahagn, M. A. & Endalifer, M. L. Epidemiology of HIV infection in the Amhara Region of Ethiopia, 2015 to 2018 surveillance data analysis. HIV AIDS (Auckl) 12, 307\u2013314 (2020).","journal-title":"HIV AIDS (Auckl)"},{"issue":"8","key":"68909_CR15","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"A Trickey","year":"2017","unstructured":"Trickey, A. et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV 4(8), e349\u2013e356 (2017).","journal-title":"Lancet HIV"},{"issue":"13","key":"68909_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1212\/WNL.0b013e3181f4d5bb","volume":"75","author":"P Vivithanaporn","year":"2010","unstructured":"Vivithanaporn, P. et al. Neurologic disease burden in treated HIV\/AIDS predicts survival: A population-based study. Neurology 75(13), 1150\u20131158 (2010).","journal-title":"Neurology"},{"key":"68909_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.581346","volume":"11","author":"J Wei","year":"2020","unstructured":"Wei, J. et al. The prevalence of frascati-criteria-based HIV-associated neurocognitive disorder (hand) in HIV-infected adults: A systematic review and meta-analysis. Front. Neurol. 11, 581346 (2020).","journal-title":"Front. Neurol."},{"issue":"1","key":"68909_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-020-01857-3","volume":"20","author":"AA Mohamed","year":"2020","unstructured":"Mohamed, A. A., Oduor, C. & Kinyanjui, D. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya. BMC Neurol. 20(1), 1\u201311 (2020).","journal-title":"BMC Neurol."},{"issue":"3","key":"68909_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/CPJ.0000000000000117","volume":"5","author":"JA Rumbaugh","year":"2015","unstructured":"Rumbaugh, J. A. & Tyor, W. HIV-associated neurocognitive disorders: Five new things. Neurol. Clin. Pract. 5(3), 224\u2013231 (2015).","journal-title":"Neurol. Clin. Pract."},{"issue":"1","key":"68909_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2334-11-356","volume":"11","author":"M Gissl\u00e9n","year":"2011","unstructured":"Gissl\u00e9n, M., Price, R. W. & Nilsson, S. The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence?. BMC Infectious Diseases 11(1), 356 (2011).","journal-title":"BMC Infectious Diseases"},{"key":"68909_CR21","unstructured":"Federal democratic republic of Ethiopia, M.o.H., Guidelines on clinical and programmatic management of major non communicable disease. National NCD guideline, 2016, 2016. https:\/\/extranet.who.int >ncdccs>Data>ETH_D1."},{"key":"68909_CR22","unstructured":"Ethiopian Federal Ministry of Health, National Comprehensive HIV Care Guideline 2018 2018. will be found at WHO Africa. https:\/\/www.afro.who.int >sites>default>files>"},{"key":"68909_CR23","doi-asserted-by":"crossref","unstructured":"Daniel, B., et al., Psychometric Properties of the Montreal Cognitive Assessment (MoCA) to Detect Major Neurocognitive Disorder Among Older People in Ethiopia: A Validation Study. Neuropsychiatric Disease and Treatment, 2022: p. 1789\u20131798.","DOI":"10.2147\/NDT.S377430"},{"key":"68909_CR24","unstructured":"MoCA Basic administration and scoring instruction. to be found at https:\/\/catch-on.org\/wp-content\/uploads\/2016\/12\/MoCA-Basic-Instructions.pdf, 2016."},{"issue":"6","key":"68909_CR25","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke, K. et al. An ultrabrief screening scale for anxiety and depression: The PHQ-4. Psychosomatics 50(6), 613\u2013621 (2009).","journal-title":"Psychosomatics"},{"key":"68909_CR26","doi-asserted-by":"crossref","unstructured":"Graf, C. The Lawton instrumental activities of daily living scale. AJN Am. J. Nursing. 108(4) (2008).","DOI":"10.1097\/01.NAJ.0000314810.46029.74"},{"issue":"1","key":"68909_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40359-018-0249-9","volume":"6","author":"R-D Kocalevent","year":"2018","unstructured":"Kocalevent, R.-D. et al. Social support in the general population: Standardization of the Oslo social support scale (OSSS-3). BMC Psychol. 6(1), 31 (2018).","journal-title":"BMC Psychol."},{"key":"68909_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17159\/sajs.2021\/8575","volume":"117","author":"MC Nweke","year":"2021","unstructured":"Nweke, M. C. et al. Meta-analysis of factors affecting prevalence estimates of HIV-associated neurocognitive disorder in sub-Saharan Africa. S. Afr. J. Sci. 117, 1\u201310 (2021).","journal-title":"S. Afr. J. Sci."},{"key":"68909_CR29","doi-asserted-by":"crossref","unstructured":"Troncoso, F.T. and L.d.O. Conterno. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population. Revista da Sociedade Brasileira de Medicina Tropical. 48, 390\u2013398 (2015).","DOI":"10.1590\/0037-8682-0034-2015"},{"key":"68909_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.814362","volume":"13","author":"Y Zenebe","year":"2022","unstructured":"Zenebe, Y. et al. Worldwide occurrence of HIV-associated neurocognitive disorders and its associated factors: A systematic review and meta-analysis. Front. Psychiatry 13, 814362 (2022).","journal-title":"Front. Psychiatry"},{"key":"68909_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2016.10.016","volume":"85","author":"M Tsegaw","year":"2017","unstructured":"Tsegaw, M. et al. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia. J. Psychiatric Res. 85, 37\u201341 (2017).","journal-title":"J. Psychiatric Res."},{"key":"68909_CR32","first-page":"425","volume":"13","author":"AD Wubetu","year":"2021","unstructured":"Wubetu, A. D., Asefa, K. K. & Gebregiorgis, B. G. Prevalence of neurocognitive impairment and associated factors among people living with HIV on highly active antiretroviral treatment, Ethiopia. HIV AIDS (Auckl) 13, 425\u2013433 (2021).","journal-title":"HIV AIDS (Auckl)"},{"issue":"10","key":"68909_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/gps.5357","volume":"35","author":"P Eaton","year":"2020","unstructured":"Eaton, P. et al. Risk factors for symptomatic HIV-associated neurocognitive disorder in adults aged 50 and over attending a HIV clinic in Tanzania. Int. J. Geriatr. Psychiatry 35(10), 1198\u20131208 (2020).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"68909_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/2325957414553839","volume":"16","author":"AJ Yusuf","year":"2017","unstructured":"Yusuf, A. J. et al. Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. J. Int. Assoc. Provid. AIDS Care 16(1), 48\u201355 (2017).","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"issue":"1","key":"68909_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/apc.2017.0202","volume":"32","author":"MRP Gasc\u00f3n","year":"2018","unstructured":"Gasc\u00f3n, M. R. P. et al. Neuropsychological assessment of 412 HIV-infected individuals in S\u00e3o Paulo, Brazil. AIDS Patient Care STDs 32(1), 1\u20138 (2018).","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"68909_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204636","volume":"14","author":"M Debalkie Animut","year":"2019","unstructured":"Debalkie Animut, M. et al. High prevalence of neurocognitive disorders observed among adult people living with HIV\/AIDS in Southern Ethiopia: A cross-sectional study. PLoS One 14(3), e0204636 (2019).","journal-title":"PLoS One"},{"issue":"9","key":"68909_CR37","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/340130","volume":"185","author":"P Kaleebu","year":"2002","unstructured":"Kaleebu, P. et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J. Infect. .Dis 185(9), 1244\u20131250 (2002).","journal-title":"J. Infect. .Dis"},{"issue":"1","key":"68909_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12977-020-00542-0","volume":"17","author":"M Kiros","year":"2020","unstructured":"Kiros, M. et al. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia. Retrovirology 17(1), 33 (2020).","journal-title":"Retrovirology"},{"issue":"7","key":"68909_CR39","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jagp.2018.03.013","volume":"26","author":"SH Shin","year":"2018","unstructured":"Shin, S. H., Kim, G. & Park, S. Widowhood status as a risk factor for cognitive decline among older adults. Am. J. Geriatr. Psychiatry 26(7), 778\u2013787 (2018).","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5","key":"68909_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/09540120903280901","volume":"22","author":"C Grov","year":"2010","unstructured":"Grov, C., Golub, S. A., Parsons, J. T., Brennan, M. & Karpiak, S. E. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 22(5), 630\u2013639. https:\/\/doi.org\/10.1080\/09540120903280901 (2010) (PMID: 20401765).","journal-title":"AIDS Care."},{"issue":"5","key":"68909_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/JNC.0000000000000036","volume":"30","author":"JK Namagga","year":"2019","unstructured":"Namagga, J. K., Rukundo, G. Z. & Voss, J. G. Prevalence and risk factors of HIV-associated neurocognitive disorders in Rural Southwestern Uganda. J. Assoc. Nurses AIDS Care 30(5), 531\u2013538 (2019).","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"68909_CR42","doi-asserted-by":"crossref","unstructured":"Peritogiannis, V., et al. Mild cognitive impairment in rural areas: Research advances and implications for clinical practice and healthcare policy. Healthcare (Basel). 10(7) (2022).","DOI":"10.3390\/healthcare10071340"},{"issue":"7","key":"68909_CR43","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/QAD.0000000000001017","volume":"30","author":"J Schouten","year":"2016","unstructured":"Schouten, J. et al. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. Aids 30(7), 1027\u20131038 (2016).","journal-title":"Aids"},{"issue":"11","key":"68909_CR44","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3390\/ijms19113594","volume":"19","author":"IS Olivier","year":"2018","unstructured":"Olivier, I. S., Cacabelos, R. & Naidoo, V. Risk factors and pathogenesis of HIV-associated neurocognitive disorder: The role of host genetics. Int. J. Mol. Sci. 19(11), 3594 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"68909_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13550280600915339","volume":"12","author":"V Valcour","year":"2006","unstructured":"Valcour, V. et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection\u2014The Hawaii Aging with HIV Cohort. J. Neurovirol. 12(5), 387\u2013391 (2006).","journal-title":"J. Neurovirol."},{"issue":"2","key":"68909_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.11648\/j.ajpn.20140202.11","volume":"2","author":"TB Mossie","year":"2014","unstructured":"Mossie, T. B. & Tegegne, M. T. HIV dementia among HIV positive people at Debre markos hospital, Northwest Ethiopia. Am. J. Psychol. Neurosci. 2(2), 18\u201324 (2014).","journal-title":"Am. J. Psychol. Neurosci."},{"issue":"1","key":"68909_CR47","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1038\/s41598-022-10474-8","volume":"12","author":"M Nweke","year":"2022","unstructured":"Nweke, M. et al. Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: A meta-analysis. Sci. Rep. 12(1), 6470 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"68909_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton, R. K. et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J. NeuroVirol. 17(1), 3\u201316 (2011).","journal-title":"J. NeuroVirol."},{"issue":"16","key":"68909_CR49","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli, N. et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76(16), 1403\u20131409 (2011).","journal-title":"Neurology"},{"issue":"2","key":"68909_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijnss.2020.03.007","volume":"7","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis. Int. J. Nursing Sci. 7(2), 238\u2013247 (2020).","journal-title":"Int. J. Nursing Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68909-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T08:02:34Z","timestamp":1723881754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68909"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68909-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19058"}}